Heterocyclic compounds as RET kinase inhibitors Grant US-11661423-B2 United States of America 30 May 2023
Heterocyclic compounds as RET kinase inhibitors Grant US-11548896-B2 United States of America 10 Jan 2023
PYRAZOLOPYRIMIDINE COMPOUNDS USEFUL AS RET INHIBITORS Application EP-4105219-A1 European Patent Office 21 Dec 2022
HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS Application EP-4104837-A2 European Patent Office 21 Dec 2022
Heterocyclic compounds as ret kinase inhibitors Grant US-10954241-B2 United States of America 23 Mar 2021
Heterocyclic compounds as RET kinase inhibitors Grant US-10844067-B2 United States of America 24 Nov 2020
COMPOUNDS USEFUL AS RET INHIBITORS Application WO-2018189553-A1 World Intellectual Property Organisation (WIPO) 18 Oct 2018
ANTI-MET IN COMBINATION WITH ANTI-VEGFR2 ANTIBODIES THERAPY FOR CANCER Application WO-2015134242-A1 World Intellectual Property Organisation (WIPO) 11 Sep 2015